Xia Wei, Zhang Qiang, Li Qian, Liang Xianchun
Department of Digestive.
Department of Oncology.
Medicine (Baltimore). 2020 Dec 4;99(49):e23522. doi: 10.1097/MD.0000000000023522.
Long non-coding RNA (lncRNA) can predict the prognosis of patients with various cancers. The relationship between lncRNA taurine upregulated gene 1 (TUG1) and the prognosis of patients with gastric carcinoma still needs to be further explored. Therefore, this study attempted to explore the relationship between TUG1 and the prognosis of patients suffering from gastric carcinoma.
The database was retrieved from China National Knowledge Infrastructure (CNKI), Chinese Biomedical literature Database (CBM), Chinese Scientific and Journal Database (VIP), Wan Fang database, PubMed, and EMBASE. Hazard ratios (HRs) and its 95% confidence interval (CIs) were applied to assess the prognostic effects of TUG1 on overall survival (OS). RevMan 5.3 software was adopted to perform meta-analysis.
The results of this meta-analysis would be submitted to peer-reviewed journals for publication.
This review provided a comprehensive overview of the relationship between TUG1 and the prognosis of patients with gastric carcinoma, and offered recommendations for clinical practices or guidelines.
长链非编码RNA(lncRNA)可预测多种癌症患者的预后。lncRNA牛磺酸上调基因1(TUG1)与胃癌患者预后之间的关系仍需进一步探索。因此,本研究试图探讨TUG1与胃癌患者预后之间的关系。
从中国知网(CNKI)、中国生物医学文献数据库(CBM)、维普中文科技期刊数据库(VIP)、万方数据库、PubMed和EMBASE检索数据库。采用风险比(HRs)及其95%置信区间(CIs)评估TUG1对总生存期(OS)的预后影响。采用RevMan 5.3软件进行荟萃分析。
本荟萃分析结果将提交给同行评审期刊发表。
本综述全面概述了TUG1与胃癌患者预后之间的关系,并为临床实践或指南提供了建议。